Indomethacin 75 mg (Sustained Release) (Indowise-75)
Indomethacin 75 mg Sustained Release Tablets
| Composition | Indomethacin 75 mg (Sustained Release) |
|---|---|
| Dosage Form | Sustained Release Tablet |
| Pack Type | Alu-Alu Blister |
| Pack Size | 10 x 10 Tablets |
| MRP | ₹ 995 |
| Therapy | Rheumatology / Orthopaedics — Non-Selective NSAID (Strong) |
| Storage | Store below 30 °C in a dry place, protected from light and moisture. |
WhatsApp EnquiryCall: +919041677932
For chemists, distributors and doctors: Indowise-75 (indomethacin 75 mg (sustained release)) is available from Trumac Healthcare on a PCD franchise with monopoly rights for your district, and as wholesale stock for licensed distributors. No franchise fee; first order from ₹25,000 – work out your margin with the PTR / PTS calculator.
About Indowise-75 SR Tablet
Indowise-75 SR Tablet contains Indomethacin 75 mg in sustained-release form — a potent non-selective NSAID particularly effective in acute gout, ankylosing spondylitis and acute musculoskeletal inflammation where milder NSAIDs are inadequate.
Indomethacin has stronger anti-inflammatory action than Diclofenac/Ibuprofen but higher CNS side effects (headache, dizziness) — reserved for cases requiring this potency.
Made for Trumac Healthcare at WHO-GMP certified partner units. Available for monopoly-based PCD pharma franchise and third-party manufacturing.
Looking up another Trumac medicine? See what every Trumac Healthcare brand is used for – A–Z in English and Hindi: Trumac Healthcare tablet uses. Take medicines only as your doctor prescribes.
Indications
- Acute gouty arthritis
- Ankylosing spondylitis
- Rheumatoid arthritis (acute flares)
- Acute musculoskeletal inflammation
Mechanism of Action
Indomethacin is a potent non-selective COX-1 and COX-2 inhibitor that suppresses prostaglandin synthesis. Stronger anti-inflammatory effect than newer NSAIDs but higher CNS penetration causing headache.
Dosage & Administration
Adults: 75 mg SR once or twice daily after food.
Side Effects
Headache (frequent), dizziness, GI upset, peptic ulcer, fluid retention, transaminase elevation.
Contraindications & Precautions
Active peptic ulcer, severe heart failure, third trimester pregnancy, severe renal/hepatic impairment, aspirin-sensitive asthma.
Storage
Store below 30 °C in a dry place, protected from light and moisture.
Offered by Trumac Healthcare, a PCD pharma franchise company, available on a monopoly basis – see the pediatric pharma franchise product list. See our full tablet range for PCD franchise. No franchise fee; minimum first order ₹25,000 – cost and documents.
Indowise-75 SR Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →
Frequently Asked Questions
What is Indowise-75 SR Tablet used for?
Indowise-75 SR Tablet contains Indomethacin 75 mg (Sustained Release). Used as per the indications described above.
How should Indowise-75 SR Tablet be taken?
As directed by your physician. Complete the prescribed course.
Is Indowise-75 SR Tablet available for PCD pharma franchise?
Yes, Trumac Healthcare offers Indowise-75 SR Tablet on monopoly-based PCD pharma franchise and for third-party manufacturing.
How should Indowise-75 SR Tablet be stored?
Store below 30 °C in a dry place, protected from light and moisture.
Is Indowise-75 SR Tablet WHO-GMP certified?
Yes, manufactured in WHO-GMP and DCGI-compliant facilities.
Related Products
